RecommendFacebook LinkedIn

Annual Report 2024

Jenoptik also successfully concluded the 2024 fiscal year with record figures for revenue and earnings. The company has also become more efficient and Jenoptik is also very well positioned financially and in terms of its balance sheet. The company is therefore looking to the future with confidence, even if the environment in our key markets is very challenging in the short term in 2025.

The fiscal year 2024 at a glance:

  • Jenoptik successfully closed the fiscal year 2024, achieving the revenue and earnings targets set at the beginning of the year despite an increasingly challenging market environment.
  • Robust revenue growth: Revenue grew by 4.7 percent to 1,115.8 million euros. This entirely organic growth was driven by contributions from all divisions.
  • Profitability further improved: Group EBITDA increased by 5.7 percent to 221.5 million euros.
  • Order intake below prior-year level: In particular due to weak demand from the automotive industry, the order intake in the past fiscal year was 5.9 percent down on the prior-year figure.
  • Continued investment in capacity expansion: The construction of our high-tech factory in Dresden progressed as planned and has been completed in the meantime.
  • Healthy free cash flow; financial and balance sheet position further improved
  • The Executive and Supervisory Boards will propose to the Annual General Meeting a dividend payment of 0.38 euros per share.
  • The 2025 outlook reflects exceptionally high market uncertainties.
  • Our take on sustainability: As an “enabler,” we use our expertise and innovative products to make an important contribution to overcome social and climate challenges, enable customers worldwide to contribute more efficiently and sustainably to conserving resources and protecting the climate.
  • We have implemented a leaner organizational structure that will enable us to operate more efficiently and strengthen our focus on core markets going forward.

Dr. Stefan Traeger, President & CEO

From a financial perspective, 2024 was another very good year for us, even in a challenging environment. Our core photonics business has significant profitable growth potential and we will continue to focus our portfolio on this. We are in an excellent financial position and our free cash flow is set to increase significantly in 2025. Our aim is to continue delivering what we promise.

Download forecast report (PDF)

Key figures

Revenue (Group)

million euros

EBITDA

million euros

Order intake

million euros

Dividend per share

Cent (AGM approval pending)

Dr. Prisca Havranek-Kosicek, Chief Financial Officer

We achieved our goals in 2024. As Chief Financial Officer, the quality of our balance sheet and cash flow are of particular importance to me. Despite continued high capital expenditure, our free cash flow is at a good level of around 103 million euros. We were able to further reduce the ratio of net debt to EBITDA, and our equity ratio is also very solid at 55.6 percent. Jenoptik is therefore a very healthy company.

Download Consolidated Financial Statement (PDF)

Highlights from the 2024 fiscal year

Dr. Ralf Kuschnereit, Member of the Executive Board

In recent years, through innovations and acquisitions, we have successfully developed Jenoptik into a company whose products are indispensable to our customers. Our core markets of semiconductors & electronics, life science & medical technology promise high growth potential for the foreseeable future.

Download the Interview with the Executive Board (PDF)

Downloads